At a pivotal moment of transformation in the global healthcare innovation landscape, China’s voice in international medical innovation is rapidly growing. Ms. Yuan Qianhui, General Manager of CCRC Medtech, has confirmed her participation as a representative of China’s CRO industry at the prestigious international summit LSI Asia (Life Sciences Intelligence), to be held in Singapore from June 10–13, 2025. She will lead strategic discussions on two key topics: “East Meets West” and “Patchwork or Pathway？Navigating Regulatory Fragmentation in APAC.”
As one of the few Chinese CROs capable of competing with global giants in international multicenter clinical trials, CCRC Medtech is redefining the value standards of cross-border healthcare innovation services with its unique “Eastern Expertise + Global Vision,” serving as a critical bridge between Eastern and Western medical innovation.
Practical Strategies for Overcoming Regulatory Barriers
In the “East Meets West” panel discussion, Julia Yuan will engage in an in-depth dialogue with executives from leading international companies such as Fosun Pharma and Pulnovo Medical. Key discussion points will include:
-
Strategic pathways for Chinese innovative drugs and devices entering global markets
-
Best practices in managing global multicenter clinical trials
-
Innovative models for East-West healthcare resource collaboration
In the more hands-on “Patchwork or Pathway？Navigating Regulatory Fragmentation in APAC,” leveraging CCRC Medtech’s extensive project experience in the region, Julia will share insights on:
-
Optimizing clinical strategies in diverse regulatory environments
-
Common challenges and solutions in cross-border approvals
-
Critical success factors for emerging market access
“It is a great responsibility to represent China’s innovative service enterprises in these two crucial agendas,” said Ms. Yuan Qianhui. “The global healthcare innovation sector is undergoing profound changes, and CCRC Medtech’s cross-border experience may offer valuable insights for the industry.”
About LSI Asia
LSI Asia is the most influential life sciences investment summit in the Asia-Pacific region, attracting global industry leaders, including multinational pharmaceutical companies, top investment institutions, and innovative enterprises. This year’s summit will take place at The Ritz-Carlton, Millenia Singapore, with over 500 professionals from 30+ countries expected to attend.
